Max International was founded by dedicated and successful entrepreneurs and executives who had a vision of helping people everywhere experience the benefits of improved glutathione production.
The original highly successful product MaxGXL was developed by Dr Robert Keller. More recently, Dr Herbert Nagasawa developed the unique compound RiboCeine, which is even more effective at raising glutathione levels than the original acclaimed MaxGXL formula. RiboCeine is the key glutathione enhancing ingredient in Cellgevity, our ultimate glutathione accelerator.
Creator of original glutathione accelerator product - Max GXL
Dr Robert Keller, the creator of MaxGXL and a pioneer in glutathione research, served on the scientific review panels for the National Institutes of Health and the VA. The Consumers' Research Council named him one of America's Top Physicians in 2003, 2004, 2005, 2006, and 2007 in the fields of Internal Medicine, Immunology and Hematology. Dr. Keller published more than 100 original articles in various scientific and medical journals and was awarded several patents.
Inventor of RiboCeine - glutathione breakthrough compound
Dr Herbert Nagasawa held joint professorships in the Department of Pharmacology and the Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals.
|
|
|
|
